BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Embryo
,
Anticancer prodrugs
,
Fenofibrate
,
rs6983267
,
EGFR
,
T cell differentiation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
angiotensin converting enzyme) 2
Summary
General Info
Curated Studies
Most Correlated Studies
Lung hypertension response to a BMPR2 mutation and ACE2 treatment
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Drug target sets for approved compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7)…
Determination of soluble angiotensin-converting enzyme 2 in saliva samples and its association with …
Functional characterisation of the ACE2 orthologues in Drosophila provides insights into the neuromu…
Nedd4-2 up-regulation is associated with ACE2 ubiquitination in hypertension.
Role of ACE2 in COVID-19].
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19
Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19
Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)
Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic…
Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ